Diabetes Research and Clinical Practice
Volume 77, Issue 1 , Pages 16-40 , July 2007

Non-invasive glucose monitoring: Assessment of technologies and devices according to quantitative criteria

  • Andrea Tura

      Affiliations

    • Metabolic Unit, ISIB-CNR, Padua, Italy
    • Corresponding Author InformationCorresponding author at: ISIB-CNR, Corso Stati Uniti 4, 35127 Padua, Italy. Tel.: +39 049 829 5786; fax: +39 049 829 5763.
    • ,
  • Alberto Maran

      Affiliations

    • Department of Clinical and Experimental Medicine, University of Padua, Italy
    • ,
  • Giovanni Pacini

      Affiliations

    • Metabolic Unit, ISIB-CNR, Padua, Italy

Received 6 April 2006 ,Accepted 25 October 2006.

References 

  1. The Future of Diabetes Diagnostics: Monitoring & Management in 2010, PJB Publications USA Inc., New York, NY, 2001.
  2. Pipeline Insight: Diabetes Drug Delivery and Diagnostics—Towards the Non-invasive Revolution, Datamonitor, London, UK, 2003.
  3. Diabetes and Diabetic Complications: Major World Markets, second ed., Kalorama Information, New York, NY, 2005.
  4. Noninvasive Glucose Monitors—Technology, Players and Prospects, Greystone Associates, Amherst, NH, 2004.
  5. Khalil OS. Non-invasive glucose measurement technologies: an update from 1999 to the dawn of the new millennium. Diabetes Technol. Ther. 2004;6:660–697
  6. Sieg A, Guy RH, Delgado-Charro MB. Noninvasive and minimally invasive methods for transdermal glucose monitoring. Diabetes Technol. Ther. 2005;7:174–197
  7. www.mendosa.com/meters.htm, Last checked 22/03/2006.
  8. Siebert M, Clauss LC, Carlisle M, Casteels B, de Jong P, Kreuzer M, et al. Health technology assessment for medical devices in Europe. What must be considered. Int. J. Technol. Assess. Health Care. 2002;18:733–740
  9. Malin SF, Ruchti TL, Blank TB, Thennadil SN, Monfre SL. Noninvasive prediction of glucose by near-infrared diffuse reflectance spectroscopy. Clin. Chem. 1999;45:1651–1658
  10. R.W. Waynant, V.M. Chenault, Overview of non-invasive fluid glucose measurement using optical techniques to maintain glucose control in diabetes mellitus (http://www.ieee.org/organizations/pubs/newsletters/leos/apr98/overview.htm. Last checked 22/03/2006).
  11. Yki-Jarvinen H, Utriainen T. Insulin-induced vasodilatation: physiology or pharmacology?. Diabetologia. 1998;41:369–379
  12. Oomen PH, Kant GD, Dullaart RP, Reitsma WD, Smit AJ. Acute hyperglycemia and hyperinsulinemia enhance vasodilatation in Type 1 diabetes mellitus without increasing capillary permeability and inducing endothelial dysfunction. Microvasc. Res. 2002;63:1–9
  13. Sibbald RG, Landolt SJ, Toth D. Skin and diabetes. Endocrinol. Metab. Clin. North Am. 1996;25:463–472
  14. Monnier VM, Bautista O, Kenny D, Sell DR, Fogarty J, Dahms W, et al. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of Type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes. 1999;48:870–880
  15. Yeh SJ, Khalil OS, Hanna CF, Kantor S. Near-infrared thermo-optical response of the localized reflectance of intact diabetic and nondiabetic human skin. J. Biomed. Opt. 2003;8:534–544
  16. Mazarevica G, Freivalds T, Jurka A. Properties of erythrocyte light refraction in diabetic patients. J. Biomed. Opt. 2002;7:244–247
  17. Fusman R, Rotstein R, Elishkewich K, Zeltser D, Cohen S, Kofler M. Image analysis for the detection of increased erythrocyte, leukocyte and platelet adhesiveness/aggregation in the peripheral blood of patients with diabetes mellitus. Acta Diabetol. 2001;38:129–134
  18. Marbach R, Koschinsky T, Gries FA, Heise HM. Non-invasive blood glucose assay by near-infrared diffuse reflectance spectroscopy of the human inner lip. Appl. Spect. 1993;47:875–881
  19. Kajiwara K, Uemura T, Kishikawa H, Nishida K, Hashiguchi Y, Uehara M, et al. Non-invasive measurement of blood glucose concentrations by analyzing Fourier transform infrared absorbance spectra through oral mucosa. Med. Biol. Eng. Comput. 1993;31:S17–S22
  20. Brancaleon L, Bamberg MP, Sakamaki T, Kollias N. Attenuated total reflection-Fourier transform infrared spectroscopy as a possible method to investigate biophysical parameters of stratum corneum in vivo. J. Invest. Dermatol. 2001;116:380–386
  21. Heise HM, Marbach R. Human oral mucosa studies with varying blood glucose concentration by non-invasive ATR-FT-IR-spectroscopy. Cell. Mol. Biol. (Noisy-le-grand). 1998;44:899–912
  22. Larin KV, Eledrisi MS, Motamedi M, Esenaliev RO. Noninvasive blood glucose monitoring with optical coherence tomography: a pilot study in human subjects. Diab. Care. 2002;25:2263–2267
  23. Heinemann L, Kramer U, Klotzer HM, Hein M, Volz D, Hermann M, et al. Noninvasive glucose measurement by monitoring of scattering coefficient during oral glucose tolerance tests. Non-Invasive Task Force. Diabetes Technol. Ther. 2000;2:211–220
  24. Yeh SJ, Hanna CF, Khalil OS. Monitoring blood glucose changes in cutaneous tissue by temperature-modulated localized reflectance measurements. Clin. Chem. 2003;49:924–934
  25. Hanlon EB, Manoharan R, Koo TW, Shafer KE, Motz JT, Fitzmaurice M, et al. Prospects for in vivo Raman spectroscopy. Phys. Med. Biol. 2000;45:R1–R59
  26. Steffes PG. Laser-based measurement of glucose in the ocular aqueous humor: an efficacious portal for determination of serum glucose levels. Diabetes Technol. Ther. 1999;1:129–133
  27. Owyoung A, Jones E. Stimulated Raman spectroscopy using low-power cw lasers. Opt. Lett. 1977;1:152–154
  28. R.V. Tarr, P.G. Steffes, The non-invasive measure of d-glucose in the ocular aqueous humor using stimulated Raman spectroscopy (http://www.ieee.org/organizations/pubs/newsletters/leos/apr98/dgloucose.htm. Last checked 22/03/2006).
  29. Yonzon CR, Haynes CL, Zhang X, Walsh JT, Van Duyne RP. A glucose biosensor based on surface-enhanced Raman scattering: improved partition layer, temporal stability, reversibility, and resistance to serum protein interference. Anal. Chem. 2004;76:78–85
  30. Caspers PJ, Lucassen GW, Puppels GJ. Combined in vivo confocal Raman spectroscopy and confocal microscopy of human skin. Biophys. J. 2003;85:572–580
  31. Rabinovitch B, March WF, Adams RL. Noninvasive glucose monitoring of the aqueous humor of the eye: part I. Measurement of very small optical rotations. Diab. Care. 1982;5:254–258
  32. R.J. McNichols, B.D. Cameron, G.L. Coté, Development of a non-invasive polarimetric glucose sensor (http://www.ieee.org/organizations/pubs/newsletters/leos/apr98/glucosesensor.htm. Last checked 22/03/2006).
  33. Rawer R, Stork W, Muller-Glaser KD. Polarimetric methods for measurement of intra ocular glucose concentration. Biomed. Tech. (Berl.). 2002;47(Suppl. 1):186–188
  34. Khalil OS. Spectroscopic and clinical aspects of noninvasive glucose measurements. Clin. Chem. 1999;45:165–177
  35. Cameron BD, Baba JS, Cote GL. Measurement of the glucose transport time delay between the blood and aqueous humor of the eye for the eventual development of a noninvasive glucose sensor. Diabetes Technol. Ther. 2001;3:201–207
  36. Shen Y, Lu Z, Spiers S, MacKenzie HA, Ashton HS, Hannigan J, et al. Measurement of the optical absorption coefficient of a liquid by use of a time-resolved photoacoustic technique. Appl. Opt. 2000;39:4007–4012
  37. http://www.integrity-app.com. Last checked 22/03/2006.
  38. MacKenzie HA, Ashton HS, Spiers S, Shen Y, Freeborn SS, Hannigan J, et al. Advances in photoacoustic noninvasive glucose testing. Clin. Chem. 1999;45:1587–1595
  39. Sandby-Moller J, Poulsen T, Wulf HC. Influence of epidermal thickness, pigmentation and redness on skin autofluorescence. Photochem. Photobiol. 2003;77:616–620
  40. Domschke A, March WF, Kabilan S, Lowe C. Initial clinical testing of a holographic non-invasive contact lens glucose sensor. Diabetes Technol. Ther. 2006;8:89–93
  41. Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am. J. Med. 1999;106:399–403
  42. Ermolina I, Polevaya Y, Feldman Y. Analysis of dielectric spectra of eukaryotic cells by computer modelling. Eur. Biophys. J. 2000;29:141–145
  43. Polevaya Y, Ermolina I, Schlesinger M, Ginzburg BZ, Feldman Y. Time domain dielectric spectroscopy study of human cells. II. Normal and malignant white blood cells. Biochim. Biophys. Acta. 1999;1419:257–271
  44. Caduff A, Hirt E, Feldman Y, Ali Z, Heinemann L. First human experiments with a novel non-invasive, non-optical continuous glucose monitoring system. Biosens. Bioelectron. 2003;19:209–217
  45. Gourzi M, Rouane A, Guelaz R, Nadi M, Jaspard F. Study of a new electromagnetic sensor for glycaemia measurement: in vitro results on blood pig. J. Med. Eng. Technol. 2003;27:276–281
  46. Gourzi M, Rouane A, Guelaz R, Alavi MS, McHugh MB, Nadi M, et al. Non-invasive glycaemia blood measurements by electromagnetic sensor: study in static and dynamic blood circulation. J. Med. Eng. Technol. 2005;29:22–26
  47. Moran GR, Jeffrey KR, Thomas JM, Stevens JR. A dielectric analysis of liquid and glassy solid glucose/water solutions. Carbohydr. Res. 2000;328:573–584
  48. Gebhart S, Faupel M, Fowler R, Kapsner C, Lincoln D, McGee V, et al. Glucose sensing in transdermal body fluid collected under continuous vacuum pressure via micropores in the stratum corneum. Diabetes Technol. Ther. 2003;5:159–166
  49. Mitragotri S, Coleman M, Kost J, Langer R. Analysis of ultrasonically extracted interstitial fluid as a predictor of blood glucose levels. J. Appl. Physiol. 2000;89:961–966
  50. Kurnik RT, Oliver JJ, Waterhouse SR, Dunn T, Jayalakshmi Y, Lesho M, et al. Application of the mixtures of experts algorithm for signal processing in a noninvasive glucose monitoring system. Sens. Actuators B: Chem. 1999;60:19–26
  51. Pitzer KR, Desai S, Dunn T, Edelman S, Jayalakshmi Y, Kennedy J, et al. Detection of hypoglycemia with the GlucoWatch biographer. Diab. Care. 2001;24:881–885
  52. Garg SK, Potts RO, Ackerman NR, Fermi SJ, Tamada JA, Chase HP. Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with Type 1 diabetes. Diab. Care. 1999;22:1708–1714
  53. Tamada JA, Garg S, Jovanovic L, Pitzer KR, Fermi S, Potts RO. Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team. JAMA. 1999;282:1839–1844
  54. Tierney MJ, Garg S, Ackerman NR, Fermi SJ, Kennedy J, Lopatin M, et al. Effect of acetaminophen on the accuracy of glucose measurements obtained with the GlucoWatch biographer. Diabetes Technol. Ther. 2000;2:199–207
  55. Tierney MJ, Tamada JA, Potts RO, Jovanovic L, Garg S. Cygnus Research Team, Clinical evaluation of the GlucoWatch biographer: a continual, non-invasive glucose monitor for patients with diabetes. Biosens. Bioelectron. 2001;16:621–629
  56. Eastman RC, Chase HP, Buckingham B, Hathout EH, Fuller-Byk L, Leptien AMM, et al. Use of the GlucoWatch biographer in children and adolescents with diabetes. Pediatr. Diab. 2002;3:127–134
  57. Gandrud LM, Paguntalan HU, Van Wyhe MM, Kunselman BL, Leptien AD, Wilson DM, et al. Use of the Cygnus GlucoWatch biographer at a diabetes camp. Pediatrics. 2004;113:108–111
  58. Nunnold T, Colberg SR, Herriott MT, Somma CT. Use of the noninvasive GlucoWatch Biographer during exercise of varying intensity. Diabetes Technol. Ther. 2004;6:454–462
  59. Sieg A, Guy RH, Delgado-Charro MB. Noninvasive glucose monitoring by reverse iontophoresis in vivo: application of the internal standard concept. Clin. Chem. 2004;50:1383–1390
  60. Dunn TC, Eastman RC, Tamada JA. Rates of glucose change measured by blood glucose meter and the GlucoWatch Biographer during day, night, and around mealtimes. Diabetes Care. 2004;27:2161–2165
  61. Tsalikian E, Kollman C, Mauras N, Weinzimer S, Buckingham B, Xing D, et al. GlucoWatch G2 Biographer alarm reliability during hypoglycemia in children. Diabetes Technol. Ther. 2004;6:559–566
  62. Hathout E, Patel N, Southern C, Hill J, Anderson R, Sharkey J, et al. Home use of the GlucoWatch G2 biographer in children with diabetes. Pediatrics. 2005;115:662–666
  63. Fiallo-Scharer R. Diabetes Research in Children Network Study Gr@oup, Eight-point glucose testing versus the continuous glucose monitoring system in evaluation of glycemic control in Type 1 diabetes. J. Clin. Endocrinol. Metab. 2005;90:3387–3391
  64. Buckingham B, Block J, Burdick J, Kalajian A, Kollman C, Choy M, et al. Diabetes Research in Children Network, response to nocturnal alarms using a real-time glucose sensor. Diabetes Technol. Ther. 2005;7:440–447
  65. Chase HP, Roberts MD, Wightman C, Klingensmith G, Garg SK, Van Wyhe M, et al. Use of the GlucoWatch biographer in children with Type 1 diabetes. Pediatrics. 2003;111:790–794
  66. Tamada JA, Davis TL, Leptien AD, Lee J, Wang B, Lopatin M, et al. The effect of preapplication of corticosteroids on skin irritation and performance of the GlucoWatch G2 Biographer. Diabetes Technol. Ther. 2004;6:357–367
  67. The Diabetes Research in Children Network (DirecNet) Study Group. Youth and parent satisfaction with clinical use of the GlucoWatch G2 Biographer in the management of pediatric Type 1 diabetes. Diabetes Care. 2005;28:1929–1935
  68. The Diabetes Research in Children Network (DirecNet) Study Group. Psychological aspects of continuous glucose monitoring in pediatric Type 1 diabetes. Pediatr. Diab. 2006;7:32–38
  69. Chase HP, Beck R, Tamborlane W, Buckingham B, Mauras N, Tsalikian E, et al. A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with Type 1 diabetes. Diabetes Care. 2005;28:1101–1106
  70. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care. 1987;10:622–628
  71. Weinzimer SA. PENDRA: the once and future noninvasive continuous glucose monitoring device?. Diabetes Technol. Ther. 2004;6:442–444
  72. Pfutzner A, Caduff A, Larbig M, Schrepfer T, Forst T. Impact of posture and fixation technique on impedance spectroscopy used for continuous and noninvasive glucose monitoring. Diabetes Technol. Ther. 2004;6:435–441
  73. Wentholt IM, Hoekstra JB, Zwart A, DeVries JH. Pendra goes Dutch: lessons for the CE mark in Europe. Diabetologia. 2005;48:1055–1058
  74. A. Caduff, F. Dewarrat, M. Talary, G. Stalder, L. Heinemann, Y. Feldman, Non-invasive glucose monitoring in patients with diabetes: a novel system based on impedance spectroscopy, Biosens. Bioelectron., 2006 (Epub ahead of print: doi:10.1016/j.bios.2006.01.031 (March 6, 2006)).
  75. Smith A, Yang D, Delcher H, Eppstein J, Williams D, Wilkes S. Fluorescein kinetics in interstitial fluid harvested from diabetic skin during fluorescein angiography: implications for glucose monitoring. Diabetes Technol. Ther. 1999;1:21–27
  76. Chuang H, Taylor E, Davison TW. Clinical evaluation of a continuous minimally invasive glucose flux sensor placed over ultrasonically permeated skin. Diabetes Technol. Ther. 2004;6:21–30

PII: S0168-8227(06)00493-1

doi: 10.1016/j.diabres.2006.10.027

Diabetes Research and Clinical Practice
Volume 77, Issue 1 , Pages 16-40 , July 2007

Article Tools

* Image Usage & Resolution